Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Skin irritation: In accordance with the testing strategy detailed in Annex VIII, column 1 of Regulation (EC) No. 1907/2006 the assessment of the endpoint ‘skin irritation or skin corrosion’  has been performed following the consecutive steps detailed in the Regulation. As such an in vitro skin corrosion study has been performed. This study is not considered as the key study because it is not sufficient for classification and labelling in accordance with Regulation (EC) No. 1272/2008 (EU CLP) and is therefore submitted as supporting data.  The key study (Warren N, 2010) is conducted according to an appropriate validated in vitro guideline and under the conditions of GLP and therefore the study is considered to be acceptable and to adequately satisfy both the guideline requirement and the regulatory requirement as a key study for this endpoint. In addition, the data is considered to be adequate and reliable for classification and labelling in accordance with Regulation (EC) No. 1272/2008 (EU CLP).

Eye irritation/corrosion:

- In accordance with the testing strategy detailed in Annex VIII, column 1 of Regulation (EC) No. 1907/2006 an in vitro study has been performed prior to conducting an in vivo study. This study is not considered as the key study because it is not sufficient for classification and labelling in accordance with Regulation (EC) No. 1272/2008 (EU CLP).

- A key study according to OECD guideline 405 (in vivo) has been performed and is considered to be adequate and reliable for use as a key study.

Key value for chemical safety assessment

Skin irritation / corrosion

Link to relevant study records

Referenceopen allclose all

Endpoint:
skin corrosion: in vitro / ex vivo
Remarks:
in vitro
Type of information:
experimental study
Adequacy of study:
key study
Study period:
The study was performed between 26 May 2010 and 28 May 2010.
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
EU Method B.40 (In Vitro Skin Corrosion: Transcutaneous Electrical Resistance Test (TER))
Deviations:
no
Qualifier:
according to guideline
Guideline:
OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Date of inspection: 15-09-2009 Date of Signature: 26-11-2009
Test system:
other: reconstituted human epidermal model
Source species:
other: reconstituted human epidermal model
Cell type:
non-transformed keratinocytes
Cell source:
other: reconstituted human epidermal model
Source strain:
other: reconstituted human epidermal model
Details on animal used as source of test system:
Not applicable
Justification for test system used:
Test method is validated for this system
Vehicle:
unchanged (no vehicle)
Details on test system:
RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used:
EPISKIN(TM)
- Tissue batch number(s):
Not given
- Delivery date:
26 May 2010 (date received)

TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure:
37°C
- Temperature of post-treatment incubation (if applicable):
37°C

REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps:
Rinsing was achieved by filling and emptying each tissue insert for approximately 40 seconds using a constant soft stream of PBS to gently remove any residual test material
- Observable damage in the tissue due to washing:
None recorded

MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration:
0.3 mg/mL
- Incubation time:
3 hours
- Spectrophotometer: Anthos 2001 miscoplate reader
- Wavelength - 540 nm



NUMBER OF REPLICATE TISSUES:
2

CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
N/A, no direct MTT interference


NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION:
One pre-incubation test and one test material

PREDICTION MODEL / DECISION CRITERIA (choose relevant statement)
- The test substance is considered to be corrosive to to skin if the mean tissue viability is:
- <35% after the 3-minute exposure period
- >=35% after the 3-minute exposure period and <35 % after the 60-minute exposure period
- >=35% after the 60-minute exposure period and <35 % after the 240-minute exposure period

- The test substance is considered to be non-corrosive to skin if the mean tissue viability is >=35% after the 240-minute exposure period
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 20 mg
- Concentration (if solution): N/A

VEHICLE
- N/A

NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 50 µL
- Concentration (if solution): 0.9% w/v

POSITIVE CONTROL
- Amount(s) applied (volume or weight): 50 µL
- Concentration (if solution): ca. 100%
Duration of treatment / exposure:
3, 60 or 240 minutes
Duration of post-treatment incubation (if applicable):
3 hours
Number of replicates:
2
Species:
other: reconstituted human epidermis model
Strain:
other: reconstituted human epidermis model
Details on test animals or test system and environmental conditions:
Not applicable
Type of coverage:
other: topical
Preparation of test site:
other: not applicable
Vehicle:
unchanged (no vehicle)
Controls:
no
Amount / concentration applied:
TEST MATERIAL

- The test Material was applied neat.

- Amount(s) applied (volume or weight with unit):
20 mg of the test material was applied to the epidermis surface.

- Concentration (if solution):
The test material was used as supplied.

VEHICLE
No vehicle used
Duration of treatment / exposure:
3, 60, 240 minute treatments
Observation period:
Not applicable
Number of animals:
Not applicable
Details on study design:
TEST SITE
- Area of exposure:
20 mg of the test materialwas applied to the epidermis surface.

- % coverage:
The test material was applied topically to the corresponding tissues ensuring uniform covering.

- Type of wrap if used:
None used

REMOVAL OF TEST SUBSTANCE
- Washing (if done):
At the end of each exposure period, each tissue was removed from the well using forceps and rinsed using a wash bottle containing Phosphate Buffered Saline Dulbeccos (PBS) with Ca++ and Mg++. Rinsing was achieved by filling and emptying each tissue insert for approximately 40 seconds using a constant soft stream of PBS to gently remove any residual test material. Each rinsed tissue was placed into the third column of the 12-well plate until all tissues were rinsed.


SCORING SYSTEM:
Quantitative MTT Assessment (percentage tissue viability)
The corrosivity potential of the test material was predicted from the relative mean tissue viabilities obtained after the 3, 60 and 240 minute treatments, compared to the mean of the negative control tissues (n=2) treated with 0.9% w/v sodium chloride solution. The relative mean viabilities were calculated in the following way:

mean OD540 of test material / mean OD540 of negative control x 100 = Relative mean tissue viability (percentage of negative control)

Classification of corrosivity potential was based upon relative viabilities for both exposure times according to the following:

3 minute exposure : <35 Corrosive (EU R35)

3 minute exposure : ≥35
and 60 minute exposure : <35 Corrosive (EU R34)

60 minute exposure : ≥35
and 240 minute exposure : <35 Corrosive (EU R34)

240 minute exposure : <35 Non-corrosive
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Mean - after 240 minutes
Value:
109.6
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Mean - after 60 minutes exposure
Value:
121.9
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
Mean - after 3 minutes exposure
Value:
0.278
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation

Direct MTT Reduction

The MTT solution containing the test material did not turn blue/purple. This was taken to indicate the test material did not reduce MTT.

6.2Test Material, Positive Control Material and Negative Control Material

Mean OD540values and viabilities for the negative control, positive control and test material are given in Table 1.

 

The relative mean viability of the test material treated tissues was as follows:

240 minutes exposure:          109.6%

60 minutes exposure:121.9%

3 minutes exposure:              156.2%

 

The qualitative evaluation of tissue viability is given in Table 2.

Following the 3, 60 and 240-Minute exposure periods the test material treated tissues appeared blue which was considered to be indicative of viable tissue.

 

Quality Criteria

The relative mean tissue viability for the positive control treated tissues was 6.20/0 relative to the negative control treated tissues following the 240-minute exposure period. The positive control acceptance criterion was therefore satisfied.

Table 1. Mean OD540Values and Viabilities for the Negative Control Material,

Positive Control Material and Test Material

Material

Exposure period

Mean OD540if duplicate tissues

Relative mean viability (%)

Negative control material

240 mins

0.178

100*

Positive control material

240 mins

0.011

6.2

Test material

240 mins

0.195

109.6

60 mins

0.217

121.9

3 mins

0.278

156.2

 

* =The mean viability of the negative control tissues is set at 100%

 

Table 2. Qualitative Evaluation of Tissue Viability (MTT uptake visual evaluation)

 

Material

Exposure period

Tissue 1

Tissue 2

Negative control material

240 mins

-

-

Positive control material

240 mins

++

++

Test material

240 mins

-

-

60 mins

-

-

3 mins

-

-

 

- = Blue tissue (viable)

+ = Blue/white tissue (semi-viable)

++ = Tissue completely white (dead)

Interpretation of results:
GHS criteria not met
Conclusions:
The test material was considered to be Non-Corrosive to the skin.

In accordance with the testing strategy detailed in Annex VIII, column 1 of Regulation (EC) No. 1907/2006 the assessment of the endpoint ‘skin irritation or skin corrosion’ has been performed following the consecutive steps detailed in the Regulation. As such an in vitro skin corrosion study has been performed. This study is not considered as the key study because it is not sufficient for classification and labelling in accordance with Regulation (EC) No. 1272/2008 (EU CLP). However, the study does support the conclusion that the reaction mass of calcium bis(dihydrogenorthophosphate) and calcium hydrogenorthophosphate has a low overall potential for skin irritation in vivo and the data can therefore be used to support the conclusions made in the key study.
Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
The study was performed between 08 June 2010 and 14 June 2010.
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
other: OECD TG Draft guideline (Version 7.6)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Date of inspection: 15 September 2009, Date of signature: 26 November 2009
Test system:
other: reconstituted human epidermal model
Source species:
other: reconstituted human epidermal model
Cell type:
non-transformed keratinocytes
Cell source:
other: not applicable
Source strain:
other:
Justification for test system used:
This method has been validated for the assessment of skin irritation
Vehicle:
unchanged (no vehicle)
Details on test system:
RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EPISKIN(TM)
- Tissue batch number(s): Not given
- Delivery date: 08 June 2010 (date received)

TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37°C
- Temperature of post-treatment incubation (if applicable): 37°C

REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps: Rinsing was achieved by filling and emptying each tissue insert for approximately 40 seconds using a constant soft stream of PBS to gently remove any residual test material
- Observable damage in the tissue due to washing: None recorded

MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 0.3 mg/mL
- Incubation time: 3 hours
- Spectrophotometer: Anthos 2001 microplate reader
- Wavelength: 540 nm

NUMBER OF REPLICATE TISSUES: 3

CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
N/A, no direct MTT interference


NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: One pre-incubation test and one test material

PREDICTION MODEL / DECISION CRITERIA (choose relevant statement)
- The test substance is considered to be irritant to skin if the mean tissue viability is <=50% after the 15-minute exposure period followed by the 42-hour post-exposure incubation period
- The test substance is considered to be non-irritant to skin if the mean tissue viability is >50% after the 15-minute exposure period followed by the 42-hour post-exposure incubation period
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): Approx 10 mg.
- Concentration (if solution): N/A

VEHICLE
- N/A but the epidermis surface had previously been moistened with 5 ul of sterile distilled water to improve contact between the solid test material and the epidermis

NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 10 µL
- Concentration (if solution): Used as supplied

POSITIVE CONTROL
- Amount(s) applied (volume or weight): 10 µL
- Concentration (if solution): 5% w/v aqueous dilution
Duration of treatment / exposure:
15 minutes
Duration of post-treatment incubation (if applicable):
42 hours
Number of replicates:
3
Irritation / corrosion parameter:
other: viability of cells
Run / experiment:
mean
Value:
100.1
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid

RESULTS

Direct MTT Reduction

The MTT solution containing the test material did not turn blue/purple which indicated that the test material did not directly reduce MTT.

Test Material, Positive Control Material and Negative Control Material

The individual and mean OD540values, standard deviations and tissue viabilities for the test material, negative control material and positive control material are given in Table 1. The mean viabilities and standard deviations of the test material and positive control, relative to the negative control are also given in Table 1.

The relative mean viability of the test material treated tissues was 94.1% after a 15-minute exposure.

The qualitative evaluation of tissue viability is given in Table 2.

Following the 15-minute exposure the test material treated tissues appeared blue which was considered indicative of viable tissue.

Quality Criteria

The relative mean tissue viability for the positive control treated tissues was ≤40% relative to the negative control treated tissues and the standard deviation value of the percentage viability was ≤20%. The positive control acceptance criterion was therefore satisfied.

The mean OD540for the negative control treated tissues was ≥0.6 and the SD value of the percentage viability was ≤20%. The negative control acceptance criterion was therefore satisfied.

 

Table 1. Mean OD540Values and Percentage Viabilities for the Negative Control Material, Positive Control Material and Test Material

Material

OD540of tissues

Mean OD540of triplicate tissues

±SD of OD540

Relative individual tissue viability (%)

Relative mean viability (%)

Negative Control Material

0.811

0.824

0.024

98.4

100*

0.809

98.2

0.852

103.4

Positive Control Material

0.053

0.033

0.018

6.4

3.9

0.025

3.0

0.020

2.4

Test Material

0.819

0.825

0.045

99.4

100.1

0.784

95.1

0.873

105.9

 



Table 2.  Qualitative Evaluation of Tissue Viability (MTT uptake visual evaluation)

 

Material

Tissue 1

Tissue 2

Tissue 3

Negative Control Material

-

-

-

Positive Control Material

++

++

++

Test Material

-

-

-

MTT visual scoring scheme
-          =         blue tissue (viable)
+         =         blue/white tissue (semi-viable)
++       =         tissue is completely white (dead)

 

SD=    Standard deviation

*=     The mean viability of the negative control tissues is set at 100%

Interpretation of results:
GHS criteria not met
Conclusions:
The test material was considered to be Non-Irritant (NI).
This study is conducted according to an appropriate validated in vitro guideline and under the conditions of GLP and therefore the study is considered to be acceptable and to adequately satisfy both the guideline requirement and the regulatory requirement as a key study for this endpoint. In addition, the data is considered to be adequate and reliable for classification and labelling in accordance with Regulation (EC) No. 1272/2008 (EU CLP). The reaction mass of calcium bis(dihydrogenorthophosphate) and calcium hydrogenorthophosphate is not considered to be classified in accordance with Regulation (EC) No. 1272/2008 (EU CLP)
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Eye irritation

Link to relevant study records
Reference
Endpoint:
eye irritation: in vivo
Remarks:
Carried out before the entry into force of the amendments to Annexes VII and VIII
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Justification for type of information:
In vivo study was carried out before the entry into force of the amendments to Annexes VII and VIII
Qualifier:
according to guideline
Guideline:
OECD Guideline 405 (Acute Eye Irritation / Corrosion)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Species:
rabbit
Strain:
New Zealand White
Details on test animals or tissues and environmental conditions:
TEST ANIMALS
- Source: Harlan Laboratories U.K. Ltd., Loughborough, UK
- Age at study initiation: twelve to twenty weeks old
- Weight at study initiation: 2.63 kg
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least five days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17 to 23°C
- Humidity (%): 30 to 70%
- Air changes (per hr): at least fifteen changes per hour
- Photoperiod (hrs dark / hrs light): twelve hours continuous light (06:00 to 18:00) and twelve hours darkness
Vehicle:
unchanged (no vehicle)
Controls:
other: The left eye remained untreated and was used for control purposes.
Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.1 mL, weighing approximately 93 mg.


Duration of treatment / exposure:
7 days
Observation period (in vivo):
7 days
Number of animals or in vitro replicates:
1
Details on study design:
REMOVAL OF TEST SUBSTANCE
- Washing (if done): None

SCORING SYSTEM:
Assessment of ocular damage/irritation was made approximately 1 hour and 24, 48 and 72 hours following treatment, according to the numerical evaluation given in Appendix 2, (from Draize J H (1977) "Dermal and Eye Toxicity Tests" In: Principles and Procedures for Evaluating the Toxicity of Household Substances, National Academy of Sciences, Washington DC p.48 to 49). Any other ocular effects were also noted. Examination of the eye was facilitated by the use of the light source from a standard ophthalmoscope. Any clinical signs of toxicity, if present, were also recorded. Additional observations were made on Days 7 and 11 to assess the reversibility of the ocular effects. The animal’s bodyweight was recorded on Day 0 (the day of dosing) and at the end of the observation period.

TOOL USED TO ASSESS SCORE: ophthalmoscope
Irritation parameter:
cornea opacity score
Basis:
animal #1
Time point:
24/48/72 h
Score:
0
Max. score:
4
Reversibility:
other: a score of 3 for corneal opacity was recorded on day 11
Irritation parameter:
iris score
Basis:
animal #1
Time point:
24/48/72 h
Score:
1
Max. score:
2
Reversibility:
not fully reversible within: 11 days
Irritation parameter:
conjunctivae score
Remarks:
redness
Basis:
animal #1
Time point:
24/48/72 h
Score:
2
Max. score:
3
Reversibility:
not fully reversible within: 11 days
Irritation parameter:
chemosis score
Basis:
animal #1
Time point:
24/48/72 h
Score:
2
Max. score:
4
Reversibility:
not fully reversible within: 11 days
Other effects:
Individual scores for ocular irritation are given in Table 1. Opalescent areas of the cornea were noted in the treated eye at the 11-Day observation.
Iridial inflammation and moderate conjunctival irritation were noted in the treated eye one hour after treatment and at the 24, 48, 72-Hour, 7 and 11-Day observations.
A pale area on the nictitating membrane, approximately 5 mm x 5 mm in size, was noted in the treated eye at 7-Day observation. Additional ocular effects noted in the treated eye at the 11-Day observation were vascularisation, with a generalised ingrowth of vessels for approximately 3 mm, over lower half of cornea, pale areas on the remainder of the nictitating membrane and lower conjunctival membrane, blood stained discharge, a white area on the nictitating membrane, approximately 10 mm x 10 mm in size, and also scattered areas on the lower conjunctival membrane, and a small area of sloughing on lower edge of the nictitating membrane, approximately 1 mm x 4 mm in size, which had almost completely detached. The reactions noted were considered to be indicative of irreversible ocular damage. Due to worsening reactions the animal was killed for humane reasons immediately after the 11-Day observation in accordance with current UK Home Office guidelines.

Table 1: Individual scores for ocular irritation

Rabbit number and sex

69653 male

IPR = 2

Time after treatment

1 hour

2 hours

48 hours

72 hours

7 days

11 days K

CORNEA

Degree of opacity

0

0

0

0

0

3

Area of cornea involved

0

0

0

0

0

2

IRIS

1

1

1

1

1

1

CONJUNCTIVA

Redness

2

2

2

2

2

2

Chemosis

2

2

2

2

2

2

Discharge

2

3

3

3

1

2

Other reactions

-

-

-

-

P

VBsWP*Sl

 

IPR = Initial pain reaction V = Vascularisation, with a generalised ingrowth of vessels for approximately 3 mm, over lower half of cornea

P = Pale area on nictitating membrane, approximately 5 mm x 5 mm in size

Bs = Blood stained discharge

P* = Pale area on remainder of nictitating membrane and lower conjunctival membrane

W = White area on nictitating membrane, approximately 10 mm x 10 mm in size, and scattered areas on lower conjunctival membrane

Sl = Sloughing, small area on lower edge of nictitating membrane approximately 1 mm x 4 mm in size, almost completely detached

K = Due to the persistence of severe reactions, animal killed for humane reasons in accordance with current UK Home Office guidelines

- = Not applicable

Interpretation of results:
Category 1 (irreversible effects on the eye) based on GHS criteria
Conclusions:
In accordance with Regulation (EC) No. 1272/2008 the reaction mass of calcium bis(dihydrogenorthophosphate) and calcium hydrogenorthophosphate is classified as Category 1: irreversible effects on the eye/serious damage to eyes due to the severe reactions noted at day 7 which led to the animal being euthanized for humane reasons.
Endpoint conclusion
Endpoint conclusion:
adverse effect observed (irritating)

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Additional information

Justification for classification or non-classification

Skin irritation/corrosion: The substance 'a reaction mass of calcium bis(dihydrogenorthophosphate) and calcium hydrogenorthophosphate is not considered to be classified for skin irritation/corrosion in accordance with Regulation (EC) No. 1272/2008 (EU CLP). The key study is considered to be adequate and reliable for the purposes of classification and therefore further testing is not considered to be scientifically justified.

Eye irritation/corrosion: An in vivo study showed serious effects at day 11 which were not expected to be reversed by day 21 and as such the animal was euthanised. In accordance with Regulation (EC) No. 1272/2008 the substance is classified as corrosive to the eyes (category 1).

There are no data (workplace or study data) to suggest that the reaction mass of calcium bis(dihydrogenorthophosphate) and calcium hydrogenorthophosphate is irritating to the respiratory tract.